Background: Venlafaxine is an antidepressant whose adverse event profile is similar to that of the SSRIs (selective serotonin reuptake inhibitors). Serious complications due to venlafaxine overdose have been described. These generally have been resolved with supportive measures alone. However, although patients usually recover even after massive intake of the drug, death may occur in rare cases.

Objective: This article reports a case of dementia after an overdose of venlafaxine.

Case Report: We present a case of severe cognitive deterioration in a 48-year-old woman after venlafaxine overdose in a suicide attempt. She became comatose after the overdose. On recovery from the coma, she suffered irreversible motor and cognitive alterations and seizures. Several factors could justify the possible association of these side effects with venlafaxine overdose: time relationship, severe focal deficit and other neurological signs, symptomatic fluctuation, relationship of serotonin networks with the cognitive functions and deficits related to the network damage, and the potential capacity of venlafaxine to damage the central nervous system. However, other alternatives, especially factors that could implicate a hypoxic encephalopathy as the origin of the dementia, cannot be entirely ruled out.

Conclusion: Venlafaxine seems to have special toxicity vis-à-vis the SSRIs, and this case adds to the literature supporting this. Cognitive function should be monitored after an overdose with venlafaxine.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2009.04.059DOI Listing

Publication Analysis

Top Keywords

venlafaxine overdose
16
cognitive deterioration
8
venlafaxine
8
overdose
7
cognitive
5
deterioration venlafaxine
4
overdose background
4
background venlafaxine
4
venlafaxine antidepressant
4
antidepressant adverse
4

Similar Publications

Background: Geriatric depression is challenging to treat owing to age-related changes in pharmacokinetics and comorbidities. Although renal insufficiency and multimorbidity are typical geriatric complications that cannot be completely separated from each other, no study has examined the influence of these factors on the serum concentrations of antidepressants. For the first time, we evaluated the effects of these factors in combination on the dose-corrected serum concentration (C/D) of antidepressants in geriatric patients.

View Article and Find Full Text PDF
Article Synopsis
  • * A case report describes a 40-year-old man who developed NMS after withdrawing from venlafaxine while taking a low dose of quetiapine, suggesting that withdrawal may be a contributing factor in NMS cases.
  • * This case highlights the importance of recognizing the risk of NMS even at low doses of quetiapine in patients without known risk factors, emphasizing the need for careful monitoring and prompt diagnosis.
View Article and Find Full Text PDF

Retrospective analysis of venlafaxine-induced hypoglycemia in patients with overdose.

Med Clin (Barc)

April 2024

Grupo de Investigación en Toxicología Clínica, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, España; Servicio de Análisis Clínicos, Unidad de Toxicología Clínica, Hospital Universitario Son Espases, Palma de Mallorca, España; Departamento de Medicina, Facultad de Medicina, Universidad de las Islas Baleares, Palma de Mallorca, España. Electronic address:

Article Synopsis
  • Recent studies showed that taking too much venlafaxine (a medication) can lead to low blood sugar, or hypoglycemia, depending on how much is taken.
  • In a study of 21 patients in the Balearic Islands, 8 of them had low blood sugar after an overdose, and those with low blood sugar had much higher levels of the drug in their system.
  • Low blood sugar was linked to younger age, less alertness, and more serious health problems like seizures and needing to be treated in the ICU.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!